Table 1 Baseline participant characteristics. Data are means (±SD).
| Baseline characteristics |
TELE Group |
Control Group |
Withdrawn Group |
| Number of subjects |
15 |
11 |
13 |
| Male gender (%) |
10 (67%) |
4 (36%) |
6 (46%) |
| Age (years) |
60.3 (9.41) |
65.1 (7.85) |
65.6 (8.37) |
| Mass (kg) |
93.3 (18.5) |
94.8 (27.8) |
91.5 (12.6) |
| BMI (kg·m-2) |
32.3 (4.45) |
33.0 (8.44) |
32.3 (4.24) |
| HbA1c (%) |
7.90 (2.39) |
7.53 (1.68) |
7.13 (.92) |
| FBG (mmol·L-1) |
8.47 (3.03) |
8.43 (2.38) |
7.32 (1.65) |
| Peak VO2 (ml·kg-1·min-1) |
21.8 (4.99) |
20.6 (3.86) |
18.7 (4.47) |
| Insulin use (%) |
0 |
36.4 |
8.3 |
| Diabetic medication (%) |
81.3 |
72.7 |
75 |
| eGFR (<59 mL·min-1·1.73 m-2) |
0 (0%) |
1 (9%) |
0 (0%) |
BMI – Body Mass Index, HbA1C% - Glycosylated Hemoglobin, FBG – Fasting Blood Glucose, GFR – Estimated Glomerular Filtration Rate
